One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial.
Anti-Fibril Depleters: The Dawn of a New Treatment Era in Transthyretin Amyloid Cardiomyopathy?.
Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome.
miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction.
Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.
An Atypical Presentation of an Occlusion Myocardial Infarction Requiring Urgent Revascularization.
Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution.
Prevalence of Apolipoprotein B and LDL Cholesterol Discordance: Insights From the VLDbL and NHANES.
Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-Term Anticoagulation: A Meta-Analysis of Randomized Clinical Trials.
Letter by Ran et al Regarding Article, "Targeting uPARAP Modifies Lymphatic Vessel Architecture and Attenuates Lymphedema".
Letter by He et al Regarding Article, "Targeting uPARAP Modifies Lymphatic Vessel Architecture and Attenuates Lymphedema".
